Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults

Journal of Zhejiang University: Science B

Volumn 13, Issue 11, 2012, Pages 948-954

  Ren, Jing Jing ^a   Dai, Xue Wei ^b   Jiang, Zheng Gang ^c   Shen, Ling Zhi ^c   Chen, Yong Di ^c   Li, Qian ^c   Ren, Wen ^d   Liu, Ying ^d   Yao, Jun ^a,b   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b NINGBO UNIVERSITY   (China)

^c ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Geometric mean titer; Hepatitis B; Immunization; Vaccines

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHINA; FEMALE; HEMOGLOBIN SC DISEASE; HEPATITIS B; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84869201336     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1200179     Document Type: Article

References (29)

1. Bonanni, P., 1995. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine, 13(s1):68-71. [doi:10.1016/0264-410X(95) 80058-L]
2. Bryan, J.P., Craig, P.G., Reyes, L., Hakre, S., Jaramillo, R., Harlan, H., MacArthy, P., Legters, L.J., 1995. Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines. Vaccine, 13(11): 978-982. [doi:10.1016/0264-410X(95)00030-5]
3. Chang, M.H., Hadzic, D., Rouassant, S.H., Jonas, M., Kohn, I.J., Negro, F., Roberts, E., Sibal, A., 2004. Acute and chronic hepatitis: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr., 39(s2):584-588. [doi:10.1097/00005176-20040 6002-00002]
4. Coates, T., Wilson, R., Patrick, G., Andre, F., Watson, V., 2001. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin. Ther., 23(3):392-403. [doi:10.1016/S0149- 2918(01)80044-8] (Pubitemid 32328745)
5. Daniels, D., Grytdal, S., Wasley, A., 2009. Surveillance for acute viral hepatitis -United States, 2007. MMWR Surveill. Summ., 58(3):1-27.
6. Dong, M.H., Lin, Y.D., Qian, Y.H., Jiang, Y., Deng, Y., Ding, S., Ren, Y.J., 2009. Immunity effect of homemade recombinant yeast-derived hepatitis B vaccine in adults. Mod. Med. J. China, 11(2):24-26.
7. Ganczak, M., Szych, Z., Korzen, M., 2009. Preoperative vaccination for HBV at Polish hospitals as a possible public health tool to limit the spread of the epidemic: a cross-sectional study. Vaccine, 27(30):3969-3974. [doi:10.1016/j.vaccine.2009.04.042]
8. Ganem, D., Prince, A.M., 2004. Hepatitis B virus infection -natural history and clinical consequences. N. Engl. J. Med., 350(11):1118-1129. [doi:10.1056/NEJMra 031087] (Pubitemid 38298992)
9. Gilbert, C.L., Klopfer, S.O., Martin, J.C., Schodel, F.P., Bhuyan, P.K., 2011. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years. Hum. Vaccin, 7(12):1336-1342. [doi:10. 4161/hv.7.12.18333]
10. Goldstein, S.T., Zhou, F., Hadler, S.C., Bell, B.P., Mast, E.E., Margolis, H.S., 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol., 34(6):1329-1339. [doi:10.1093/ije/dyi206] (Pubitemid 41819540)
11. Gong, X.Y., Zhong, J.Y., 2009. Evaluation of Immunogenicity of 10 μg Recombinant yeast-derived hepatitis B vaccine in adults. China Prevent Med., 10(10):934-936 (in Chinese).
12. Jilg, W., Schmidt, M., Deinhardt, F., 1988. Persistence of specific antibodies after hepatitis B vaccination. J. Hepatol., 6(2):201-207. [doi:10.1016/S0168-8278(88) 80032-1]
13. Lavanchy, D., 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat., 11(2):97-107. [doi:10.1046/j.1365-2893.2003.00487.x] (Pubitemid 38365759)
14. Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., et al., 2009a. Epidemiological serosurvey of hepatitis B in China -declining HBV prevalence due to hepatitis B vaccination. Vaccine, 27(47):6550-6557. [doi:10.1016/j.vaccine.2009. 08.048]
15. Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., Zhang, Y., Liu, J., Gong, X., Chen, Y., et al., 2009b. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J. Infect. Dis., 200(1): 39-47. [doi:10.1086/599332]
16. Lu, F.M., Zhuang, H., 2009. Management of hepatitis B in China. Chin. Med. J. (Engl.), 122(1):3-4.
17. Mast, E.E., Mahoney, F.J., Alter, M.J., Margolis, H.S., 1998. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine, 16(Suppl.): 48-51. [doi:10.1016/S0264-410X(98)00294-1]
18. Mast, E.E., Weinbaum, C.M., Fiore, A.E., Alter, M.J., Bell, B.P., Finelli, L., Rodewald, L.E., Douglas, J.M.Jr., Janssen, R.S., Ward, J.W., 2006. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR Recomm. Rep., 55(RR-16):1-33, quiz CE31-CE34.
19. Rendi-Wagner, P., Kundi, M., Stemberger, H., Wiedermann, G., Holzmann, H., Hofer, M., Wiesinger, K., Kollaritsch, H., 2001. Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine, 19(15-16): 2055-2060. [doi:10.1016/S0264-410X(00)00410-2] (Pubitemid 32178355)
20. Shen, L.Z., Yao, J., 2011. Study development on booster immune strategy of hepatitis B vaccine. Zhejiang J. Prevent. Med., 23(12):22-25 (in Chinese).
21. Trivello, R., Chiaramonte, M., Ngatchu, T., Baldo, V., Majori, S., Moschen, M.E., Simoncello, I., Renzulli, G., Naccarato, R., 1995. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine, 13(2):139-141. [doi:10. 1016/0264-410X(95)93126-T]
22. Weinbaum, C.M., Williams, I., Mast, E.E., Wang, S.A., Finelli, L., Wasley, A., Neitzel, S.M., Ward, J.W., 2008. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm. Rep., 57(RR-8):1-20.
23. WHO (World Health Organization), 2000. Hepatitis B. WHO, Geneva, Switzerland. Available from http://www.who. int/mediacentre/factsheets/fs204/en [Accessed on 2 June 2010].
24. Yao, J., Chen, Y.D., 2009. Immunity effect of domestic hepatitis B vaccine in adults. China Prevent Med., 10(4): 258-261 (in Chinese).
25. Yao, J., Ren, J.J., Shen, L.Z., Chen, Y.D., Liang, X.F., Cui, F.Q., Li, Q., Jiang, Z.G., Wang, F.Z., 2011. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination. Hum. Vaccin., 7(10):1055-1059. [doi:10.4161/hv.7.10. 15990]
26. Young, M.D., Gooch, W.M.3rd, Zuckerman, A.J., Du, W., Dickson, B., Maddrey, W.C., 2001. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination. J. Med. Virol., 64(3): 290-298. [doi:10.1002/jmv.1049] (Pubitemid 32565125)
27. Yuan, Y.B., Zheng, X.H., Wang, Z.Q., 2003. Study on the immuno-effects and security of Chinese Hamster Ovary (CHO) cell hepatitis B vaccine among adults, under different dosages. Chin. J. Infect. Dis., 21(6):423-424 (in Chinese).
28. Zhang, W., Lin, C., Han, L., Li, L., Gao, P., Lin, H., Gong, X., Huang, F., Tang, Y., Ma, J., 2010. Study on the immuno-effects and influencing factors of Chinese Hamster Ovary (CHO) cell hepatitis B vaccine among adults, under different dosages. Chin. J. Epidemiol., 31(7): 767 (in Chinese).
29. Zuckerman, J., Langer, B., 2005. Hepatitis B vaccination in a school age population: a feasibility study. J. Med. Virol., 76(1):47-54. [doi:10.1002/jmv.20335] (Pubitemid 40446454)